Benchmark raised the firm’s price target on Dave (DAVE) to $119 from $95 and keeps a Buy rating on the shares. Shares have increased in value by 1,009% year-to-date, so it might “simply make sense for investors to ask at this point whether they had missed the trade on the name.” However, the firm believes Dave’s growth prospects are not fully reflected in the current valuations, especially since “such prospects have improved significantly” and the firm views Dave as “well positioned to drive additional gains” by sustaining operating momentum.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks